How is Cimzia Administered?

Cimzia is given as a subcutaneous injection in either the abdomen or thigh. Your healthcare provider will demonstrate how to use the pre-filled syringe or auto-injector. The dosing schedule varies depending on the condition treated and the specific regimen prescribed by your healthcare provider.

Important Information for Cimzia Users:

• How to Use: Adhere to your healthcare provider’s instructions for injecting Cimzia.
• Storage: Store Cimzia in the refrigerator. Allow it to reach room temperature before use.
• Side Effects: Common side effects include upper respiratory infections, rash, urinary tract infections, and injection site reactions. Report any severe or unusual symptoms to your doctor.
• Monitoring: Regular medical check-ups and blood tests are necessary to monitor your health and the medication’s effectiveness.

Medication Warnings

• Infections: Cimzia may compromise your immune system, elevating the risk of serious infections. Report any signs of infection, such as fever, chills, or persistent cough, to your doctor immediately.
• Cancer Risk: There is a potential increased risk of certain cancers, including lymphoma. Discuss your medical history and risk factors with your doctor.
• Allergic Reactions: Seek immediate medical help if you experience symptoms like rash, itching, swelling, dizziness, or trouble breathing.
• Heart Failure: Cimzia may cause or exacerbate heart failure. Inform your healthcare provider if you experience symptoms such as shortness of breath, ankle or feet swelling, or sudden weight gain.
• Nervous System Problems: There is a risk of nervous system issues, such as multiple sclerosis and seizures. Inform your doctor if you have a history of these conditions or if you experience new symptoms.

Who Should and Shouldn’t Take Cimzia?

• Suitable Candidates:
  • Adults with specified autoimmune diseases requiring TNF inhibition.
• Unsuitable Candidates:
  • Individuals with severe, active infections.
  • Patients with known hypersensitivity to certolizumab pegol or any component of the product.
  • Those with severe heart failure or pre-existing severe nervous system disorders, unless assessed and monitored closely by a healthcare professional.